Abiopharma

High Tides German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Shareholder Alert: Ademi LLP investigates whether Huntsman Corporation is obtaining a Fair Price for Public Shareholders

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

Change - Announcement of Appointment: Appointment of Independent Non-Executive Director

Designated Market Maker (DMM) Obligations: Guotai Junan Investments (Hong Kong) Limited suspends quotation of ICBC CSOP FTSE CHN GOV BD ETF

General Announcement: Outcome of Legal Proceedings and Filing of Notice of Appeal by Wholly-Owned Subsidiary

Net Asset Value(s)

CarMax Reports First Quarter Fiscal 2027 Results

X Financial Announces Leadership Change